Galapagos NV
GLPG
#4738
Rank
C$2.75 B
Marketcap
C$41.03
Share price
-1.14%
Change (1 day)
19.50%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): C-$0.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.47. In 2024 the company made an earnings per share (EPS) of C$1.63 a decrease over its 2023 EPS that were of C$4.95.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.67-141.16%
2024C$1.63-67.16%
2023C$4.95-199.64%
2022C-$4.9799.03%
2021C-$2.50-68.98%
2020C-$8.04-298.06%
2019C$4.06-554.64%
2018C-$0.89-77.18%
2017C-$3.92-326.21%
2016C$1.73-134.19%
2015C-$5.06-371.34%
2014C$1.87-445.98%
2013C-$0.5432.88%
2012C-$0.41-82.07%
2011C-$2.26-817.9%
2010C$0.3212.73%
2009C$0.28-120.79%
2008C-$1.35-37.67%
2007C-$2.1639.64%
2006C-$1.5528.17%
2005C-$1.216.25%
2004C-$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.53-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.23-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.34-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.88-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.19-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$8.27-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.25-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.85 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.73-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel